Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 31;9(6):293.
doi: 10.3390/antibiotics9060293.

The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science

Affiliations
Review

The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science

Enzo Ierardi et al. Antibiotics (Basel). .

Abstract

Helicobacter pylori (H. pylori) may enter a non-replicative, non-culturable, low metabolically active state, the so-called coccoid form, to survive in extreme environmental conditions. Since coccoid forms are not susceptible to antibiotics, they could represent a cause of therapy failure even in the absence of antibiotic resistance, i.e., relapse within one year. Furthermore, coccoid forms may colonize and infect the gastric mucosa in animal models and induce specific antibodies in animals and humans. Their detection is hard, since they are not culturable. Techniques, such as electron microscopy, polymerase chain reaction, loop-mediated isothermal amplification, flow cytometry and metagenomics, are promising even if current evidence is limited. Among the options for the treatment, some strategies have been suggested, such as a very high proton pump inhibitor dose, high-dose dual therapy, N-acetycysteine, linolenic acid and vonoprazan. These clinical, diagnostic and therapeutic uncertainties will represent fascinating challenges in the future.

Keywords: Helicobacter pylori; antibiotic resistance; coccoid form; real time polymerase chain reaction; therapy; viable non culturable.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Transition from spiral-shaped viable form of H. pylori to viable but non culturable (VBNC) coccoid forms (scanning electron microscope) and factors affecting this process.

References

    1. Ierardi E., Goni E., Losurdo G., Di Mario F. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2014;19(Suppl. 1):27–31. doi: 10.1111/hel.12157. - DOI - PubMed
    1. Gasbarrini G., Genta R.M., Anti M., Fox J., Caselli M., Doglioni C., Ierardi E., Masala G., Palli D., Testoni P.A., et al. Update on Helicobacter pylori research. Malignancies. Eur. J. Gastroenterol. Hepatol. 1997;9:621–623. doi: 10.1097/00042737-199706000-00016. - DOI - PubMed
    1. Zullo A., Hassan C., Cristofari F., Andriani A., De Francesco V., Ierardi E., Tomao S., Stolte M., Morini S., Vaira D. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin. Gastroenterol. Hepatol. 2010;8:105–110. doi: 10.1016/j.cgh.2009.07.017. - DOI - PubMed
    1. Zagari R.M., Romano M., Ojetti V., Stockbrugger R., Gullini S., Annibale B., Farinati F., Ierardi E., Maconi G., Rugge M., et al. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. Dig. Liver Dis. 2015;47:903–912. doi: 10.1016/j.dld.2015.06.010. - DOI - PubMed
    1. Ierardi E., Giorgio F., Losurdo G., Di Leo A., Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J. Gastroenterol. 2013;19:8168–8180. doi: 10.3748/wjg.v19.i45.8168. - DOI - PMC - PubMed

LinkOut - more resources